News
2h
Vietnam Investment Review on MSNInnovent Showcases Breakthrough Preclinical Data on Novel Antibodies at AACR 2025SAN FRANCISCO and SUZHOU, China, April 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.
A groundbreaking new urine test could soon help spot the early warning signs of lung cancer long before symptoms appear.
HT-KIT, a novel targeted therapy for GIST, demonstrated the ability to reduce tumor burden in humanized mouse models and induce tumor cell death.
With an FDA review underway, Johnson & Johnson is aiming to “fundamentally change” how bladder cancer is treated. | With an ...
Immunotherapy let some cancer patients with mismatch repair deficient tumors completely avoid surgery, chemo and radiation, a ...
For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...
Dostarlimab effectively eliminates the need for surgery in patients with advanced mismatch repair-deficient (dMMR) tumors, ...
Researchers have developed an AI system that predicts brain tumor recurrence in children using sequential MRI scans. By ...
This discovery opens the door for new kinds of treatments. If doctors could develop drugs that block CD9 or stop cancer cells ...
Learn about a clinical trial that used immunotherapy alone to treat people with several different types of cancer, meaning they did not need to undergo surgery, radiation or chemotherapy.
By using a compound derived from a Himalayan fungus and used for centuries in Chinese medicine as a jumping off point, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results